CEO Buys Major Convertible Stock & Warrants at Azitra – A Sign of Strong Confidence in Biotech Future
CEO buys Azitra Inc. convertible stock & warrants amid $31M private placement—insider confidence, potential upside vs. dilution risk.
3 minutes to read